Russell Investments Group Ltd. raised its position in Baxter International Inc. (NYSE:BAX – Free Report) by 6.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,522,036 shares of the medical instruments supplier’s stock after acquiring an additional 223,126 shares during the quarter. Russell Investments Group Ltd.’s holdings in Baxter International were worth $84,529,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently bought and sold shares of BAX. BlackRock Inc. purchased a new stake in Baxter International during the second quarter worth about $1,744,874,000. Pzena Investment Management LLC purchased a new position in shares of Baxter International in the second quarter valued at approximately $1,392,098,000. Equity Investment Corp purchased a new position in shares of Baxter International in the second quarter valued at approximately $146,815,000. Bank of America Corp DE purchased a new position in shares of Baxter International in the second quarter valued at approximately $132,993,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Baxter International in the second quarter valued at approximately $68,036,000. 90.19% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities research analysts recently weighed in on the stock. JPMorgan Chase & Co. cut their target price on shares of Baxter International from $26.00 to $25.00 and set a “neutral” rating on the stock in a research note on Friday, October 30th. Stifel Nicolaus raised their price target on shares of Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Wall Street Zen raised shares of Baxter International from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Wolfe Research began coverage on shares of Baxter International in a research note on Tuesday, October 20th. They issued a “peer perform” rating for the company. Finally, TD Cowen upped their price objective on Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday, July 27th. One investment analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Reduce” and a consensus target price of $23.27.
Check Out Our Latest Research Report on BAX
Baxter International Stock Up 0.1%
Shares of BAX traded up $0.03 during midday trading on Friday, hitting $25.77. The company had a trading volume of 4,491,214 shares, compared to its average volume of 7,506,119. Baxter International Inc. has a 1 year low of $15.73 and a 1 year high of $30.00. The firm has a market capitalization of $13.33 billion, a P/E ratio of -18.28, a P/E/G ratio of 3.78 and a beta of 0.68. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.19 and a current ratio of 1.79. The company’s 50-day simple moving average is $24.54 and its 200-day simple moving average is $21.67.
Baxter International (NYSE:BAX – Get Free Report) last released its earnings results on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. The firm had revenue of $2.98 billion for the quarter, compared to analyst estimates of $2.91 billion. Baxter International had a negative net margin of 6.23% and a positive return on equity of 16.23%. The business’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.69 earnings per share. As a group, sell-side analysts expect that Baxter International Inc. will post 2.10 EPS for the current year.
Baxter International Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, November 27th will be issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, November 27th. Baxter International’s payout ratio is -2.84%.
Baxter International Profile
Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.
Further Reading
- Five stocks we like better than Baxter International
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.
